RAI1 and Smith-Magenis syndrome: More specifically, 86% of SMS patients (30/35) had heterozygous deletions at the 17p11.2 region (including RAI1), while 5 SMS patients (14%) had RAI1 pathogenic variants (as detailed in Table 2).